Medical devices are crucial for providing reliable data that physicians and patients depend on to make informed treatment decisions. These devices undergo rigorous testing and are highly regulated to ensure their safety and effectiveness. But what happens when these regulations are not followed?
Some companies go to extreme lengths to manipulate regulations and sell products that are untested and unreliable. A prime example of this is the cardiac monitoring device RX-1 Mini, produced by VivaQuant. The original RX-1, launched in 2020, was a legitimate device that met regulatory standards. However, VivaQuant later released the RX-1 Mini, which significantly differs from its predecessor.
